Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016

Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Multiple Sclerosis (MS) Therapeutics market to grow at a CAGR of 3.16 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rising diagnosis and treatment rates. The Global MS Therapeutics market has also been witnessing the emergence of biomarkers. However, the lack of therapies available to manage the progression of the disease could pose a challenge to the growth of this market. 
TechNavio's report, the Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global MS Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Bayer HealthCare AG, Biogen Idec Inc., Merck Serono SA, Novartis AG, and Teva Pharmaceutical Industries Ltd.
The other vendors mentioned in this report are AB Science, Abbvie Inc., Active Biotech AB, Astra Zeneca plc, Glaxo Smith Kline plc, Glenmark Pharmaceuticals Ltd., Hoffmann-La Roche Inc., and Sanofi SA.
Key questions answered in this report: 
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Global MS Market

Market Size and Forecast

06.2 MS Market in the US

Market Size and Forecast

06.3 MS Market in Europe

Market Size and Forecast

06.4 Five Forces Analysis

07. Geographical Segmentation

08. Rate of Incidence and Prevalence

09. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends


15.1 Bayer HealthCare AG

Business Overview

Key Information

SWOT Analysis

15.2 Biogen Idec Inc.

Business Overview

Key Information

SWOT Analysis

15.3 Merck Serono SA

Business Overview

Key Information

SWOT Analysis

15.4 Novartis AG

Business Overview

Key Information

SWOT Analysis

15.5 Teva Pharmaceutical Industries Ltd.

Business Overview

Key Information

SWOT Analysis

16. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global MS Market 2012-2016 (US$ billion)

Exhibit 3: MS Market in the US 2012-2016 (US$ billion)

Exhibit 4: MS Market in Europe 2012-2016 (US$ billion)

Exhibit 5: Global MS Market by Geographical Segmentation 2012

Exhibit 6: Global MS Market by Vendor Segmentation 2012

Exhibit 7: Business Segmentation of Bayer HealthCare AG

Exhibit 8: Business Segmentation of Merck Serono SA

Exhibit 10: Business Segmentation of Novartis AG

Exhibit 12: Business Segmentation of Teva Pharmaceuticals Industries Ltd.



 


Enquiry Before Buy
image
Can´t read the image ? refresh here.